Cargando…

Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis

INTRODUCTION: Calprotectin, a heterodimeric complex of S100A8/9 (MRP8/14), has been proposed as an important serum biomarker that reflects disease activity and structural joint damage in rheumatoid arthritis (RA). The objective of this cross-sectional study was to test the hypothesis that calprotect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hurnakova, Jana, Zavada, Jakub, Hanova, Petra, Hulejova, Hana, Klein, Martin, Mann, Herman, Sleglova, Olga, Olejarova, Marta, Forejtova, Sarka, Ruzickova, Olga, Komarc, Martin, Vencovsky, Jiri, Pavelka, Karel, Senolt, Ladislav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572609/ https://www.ncbi.nlm.nih.gov/pubmed/26373925 http://dx.doi.org/10.1186/s13075-015-0764-5

Ejemplares similares

Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study
por: Hurnakova, Jana, et al.
Publicado: (2017)

Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission
por: Hurnakova, Jana, et al.
Publicado: (2016)

The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis – a cohort study
por: Závada, Jakub, et al.
Publicado: (2017)

Chemokine and Cytokine Profiles in Patients with Hand Osteoarthritis
por: Baloun, Jiří, et al.
Publicado: (2020)

New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis
por: Navrátilová, Adéla, et al.
Publicado: (2023)

Lower serum clusterin levels in patients with erosive hand osteoarthritis are associated with more pain
por: Kropáčková, Tereza, et al.
Publicado: (2018)

IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis
por: Navrátilová, Adela, et al.
Publicado: (2021)

Pentosidine, an Advanced Glycation End-Product, May Reflect Clinical and Morphological Features of Hand Osteoarthritis
por: Braun, Martin, et al.
Publicado: (2012)

Clusterin serum levels are elevated in patients with early rheumatoid arthritis and predict disease activity and treatment response
por: Kropáčková, Tereza, et al.
Publicado: (2021)

Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis
por: Levitova, Andrea, et al.
Publicado: (2016)

Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis
por: Andrés Cerezo, Lucie, et al.
Publicado: (2011)

Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis
por: Šenolt, Ladislav, et al.
Publicado: (2015)

Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study
por: Závada, Jakub, et al.
Publicado: (2015)

High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis
por: Prajzlerová, Klára, et al.
Publicado: (2021)

Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study
por: Heřmánková, Barbora, et al.
Publicado: (2021)

The effect of a 24-week training focused on activities of daily living, muscle strengthening, and stability in idiopathic inflammatory myopathies: a monocentric controlled study with follow-up
por: Špiritović, Maja, et al.
Publicado: (2021)

Decreased Circulating Visfatin Is Associated with Improved Disease Activity in Early Rheumatoid Arthritis: Data from the PERAC Cohort
por: Sglunda, Ondřej, et al.
Publicado: (2014)

Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis
por: Prajzlerová, Klára, et al.
Publicado: (2017)

S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity
por: Šumová, Barbora, et al.
Publicado: (2020)

Hsp90 Levels in Idiopathic Inflammatory Myopathies and Their Association With Muscle Involvement and Disease Activity: A Cross-Sectional and Longitudinal Study
por: Štorkánová, Hana, et al.
Publicado: (2022)

Female Sexual Dysfunction and Pelvic Floor Muscle Function Associated with Systemic Sclerosis: A Cross-Sectional Study
por: Heřmánková, Barbora, et al.
Publicado: (2022)

Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis
por: Andrés Cerezo, Lucie, et al.
Publicado: (2015)

Interleukin-37: associations of plasma levels and genetic variants in gout
por: Andres Cerezo, Lucie, et al.
Publicado: (2023)

Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
por: Štorkánová, Hana, et al.
Publicado: (2021)

Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis
por: Andrés Cerezo, Lucie, et al.
Publicado: (2017)

Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
por: Štorkánová, Hana, et al.
Publicado: (2021)

Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650
por: Štorkánová, Hana, et al.
Publicado: (2023)

Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study
por: Heřmánková, Barbora, et al.
Publicado: (2023)

Resistin in idiopathic inflammatory myopathies
por: Filková, Mária, et al.
Publicado: (2012)

Hsp90 as a Myokine: Its Association with Systemic Inflammation after Exercise Interventions in Patients with Myositis and Healthy Subjects
por: Švec, Xiao, et al.
Publicado: (2022)

S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils
por: Navrátilová, Adéla, et al.
Publicado: (2021)

Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria: baseline clinical characteristics and subset differences in a single-centre cohort
por: Bubová, Kristyna, et al.
Publicado: (2019)

The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies
por: Pleštilová, Lenka, et al.
Publicado: (2014)

MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis
por: Hruskova, Veronika, et al.
Publicado: (2016)

Pentosidine in serum and synovial fluid in patients with knee osteoarthritis and its potential role of prediction of osteoarthritis progression
por: Pavelka, K, et al.
Publicado: (2003)

OPG and RANKL in serum and synovial fluids of patients with rheumatoid arthritis, osteoarthritis and spondylarthropathy
por: Krystufkova, O, et al.
Publicado: (2003)

Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis
por: Kryštůfková, Olga, et al.
Publicado: (2018)

The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab
por: Hammer, Hilde Berner, et al.
Publicado: (2011)

The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry
por: Skácelová, Martina, et al.
Publicado: (2022)

Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry
por: Nekvindová, Lucie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l95n94rvjo7029k071vd043nvu